Navigation Links
Hospira to Host Conference Call for Second-Quarter 2009 Results
Date:6/26/2009

LAKE FOREST, Ill., June 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its second-quarter 2009 results on Wednesday, July 29, 2009, at 8 a.m. Central time.

The company will release its second-quarter 2009 results earlier that morning, before the U.S. stock market open and the conference call.

A live webcast of the conference call will be available on Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the webcast. A replay will be available on the Hospira Web site for 30 days following the call.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
2. Hospira to Present at Bank of America and Merrill Lynch 2009 Health Care Conference May 13
3. Hospira Launches Biologics Clock and Web Resource to Raise Awareness of Potential Biogenerics Impact
4. Hospira Reports First-Quarter 2009 Results
5. Hospira to Host Conference Call for First-Quarter 2009 Results
6. Hospira to Present at Cowen and Companys 29th Annual Health Care Conference March 17
7. Hospira Expands Board of Directors
8. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
9. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
10. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
11. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...KELOWNA,BC,Nov.27/PRNewswire/-UploadableUSBpedomet...ness.Acombinationofadvancedaccelerometerfunctional...novertheaccuracyofself-reporteddata.It,snowpossibl...afitnessprogram. ,, CoreHealthTechnologiesisone...gy."Ourhealthchallengesareeasytoadministerandparti...
(Date:11/27/2009)...SANFRANCISCO,Nov.27/PRNewswire-FirstCall/--TheGymb...mbert,CFO/COO,willpresentattheNASDAQOMX23rdInvesto...England,onWednesday,December2,2009,at11:45a.m.GMT....ation,spresentationovertheInternet,pleaselogontoww...page,goto"InvestorandMediaRelations"andthen"Confer...
(Date:11/27/2009)...KIBBUTZSHAMIR,Israel,Nov.27/PRNewswire-FirstCall/-..." ),aleadingproviderofinnovativeproductsandtechnol...boardofdirectorshaddeclaredadividenddistributionin....62millionbasedontheNovember25,2009representativer...lyNIS2.3basedontheNovember25,2009representativerat...
(Date:11/27/2009)...rates to bring unprecedented medical, economic bur... (HealthDay News) -- The number of people with dia...ver the next 25 years, a new study predicts. , ...illion people with the disease, up from 23.7 milli...ting people with diabetes will triple, the study a...
(Date:11/27/2009)... Multi-purpose bilingual coloring...d for use by the business community to educate - i...ubjects from Safety issues to Dinosuars to ABC,S a... Saint Louis, MO (PRWEB) November 27, 2009 -- T...nics or toys to keep them busy any hour of the day...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...e officer for Aboriginal Medical Services Alliance...nal communities could be provided// better access ...on over the Internet if funds of $1 million are gr... medical practices and health centres who adopt br...
...ts during pregnancy may lead to various health com... E is an anti-oxidant found naturally in foods lik...ch had suggested that vitamin E, particularly take...ital in London, warned that pregnant women could b...
... it was found that researchers at the UC Davis Can...ce of amino acids // . The speciality of this disc...finity, stability and specificity towards leukemic...ublished in the journal Nature Chemical Biology. ‘...
...abetes, one of the world’s leading debilitating di...It affects an estimated 194 million adults worldwi...ve and effective therapeutic options that are bene...the cases. This type is the direct result of the b...
... seizures, or psychogenic seizures are often misdi...ed by psychological condition //whereas epilepsy i...e brain. Because these nonepileptic seizure...ntific journal of the American Academy of Neurolog...
...e chips have been used by a pediatric research tea...order to identify small defects that lead to gene...c tests usually cannot detect these abnormalities,... years, many children who have multiple congenital...
Other Medicine News:Health News:New Molecular Treatment Identified To Treat Blood Cell Cancers 2Health News:Inhaled Insulin: A New Modality for Management of Diabetes 2Health News:Clues To Identify Psychological Seizures 2Health News:Clues To Identify Psychological Seizures 3Health News:Hunt for Chromosomal Errors Which Cause Genetic Diseases 2Health News:Hunt for Chromosomal Errors Which Cause Genetic Diseases 3Health News:Hunt for Chromosomal Errors Which Cause Genetic Diseases 4
(Date:11/25/2009)...PRNewswire-FirstCall/--Hologic,Inc.(HologicortheCo...erandsupplierofpremiumdiagnostics,medicalimagingsy...hcareneedsofwomen,isusingtheannualmeetingoftheRadi...einChicago,November29throughDecember3,2009tohighli...cmammographyworkstationsoftware. ,, TheHologicS...
(Date:11/25/2009)...25/PRNewswire/--TheFDAgrantedtraditionalapprovalfo...ereversetranscriptaseinhibitor(NNRTI).INTELENCEist...experiencedadultswhoareexperiencingvirologicfailur...roviral(ARV)agents.Thetraditionalapprovalisbasedon...T-2.INTELENCEiscurrentlymarketedintheU.S.byTibotec...
(Date:11/25/2009)...RNewswire-Asia-FirstCall/--ChinaSkyOne,Medical,Inc... ),a,leadingfullyintegratedpharmaceuticalcompanyde...ple,sRepublicofChina("PRC"),today,announcedthatthe...r,theControlofPharmaceuticalandBiologicalProducts(...nosticKitforHumanProstateSpecific,Antigen(Colloida...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Study aims to induce recovery from ankylosing spondylitis 52298 1Study aims to induce recovery from ankylosing spondylitis 52298 2Tires made from trees better cheaper more fuel efficient 9304 1Tires made from trees better cheaper more fuel efficient 9304 2Preimplantation genetic diagnosis may pose neurological risks 9300 1Preimplantation genetic diagnosis may pose neurological risks 9300 2
...ted the Clinical Potential of Peregrine,s,Unique S...tive as,Avastin(R) in Animal Cancer Models, TUSTIN...,Peregrine Pharmaceuticals, Inc. , a clinical stag...noclonal antibodies,for the treatment of cancer an... data from multiple studies presented at the recen...
...SS WIRE)--Apr 23, 2007 - Affitech AS, the,human an...eregrine,Pharmaceuticals, Inc. reported positive i...l antibody developed by Affitech, in a,pancreatic ...Annual,Meeting of the American Association for Can...wo companies for selective blocking of,VEGF (vascu...
Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7Positive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine 2
ABX Pentra 80
...is an easy-to-use, workflow-based system designed ...ex consists of the SleepWorks software and either ...rable systems can be used for a complete range of ...g full EEG recording - and have superior signal qu...
...d-alone microprocessor-controlled photometer desig...ell microplates using single- or dual- wavelength ...velength) and a dynamic reading range up to 4.0 OD...ry or assay requirements. Self-diagnostics (up to ...
Variant II Total GHb Program
Medicine Products: